First-Line Treatment with Tivozanib for Metastatic Renal Cell Carcinoma in Real-World Settings Across Germany: Results of the Prospective, Non-Interventional, Post-Approval Study T-Rex.
Saved in:
| Title: | First-Line Treatment with Tivozanib for Metastatic Renal Cell Carcinoma in Real-World Settings Across Germany: Results of the Prospective, Non-Interventional, Post-Approval Study T-Rex. |
|---|---|
| Authors: | Grünwald, Viktor1 (AUTHOR) viktor.gruenwald@uk-essen.de, Rußwurm, Karen2 (AUTHOR), Eckert, Ralf3 (AUTHOR), Seseke, Sandra4 (AUTHOR), Standhaft, Diana5 (AUTHOR), Hegemann, Miriam6 (AUTHOR), Baumann, Steffen7 (AUTHOR), Brenneis, Horst8 (AUTHOR), Seidel, Michael9 (AUTHOR), Rau, Olrik10 (AUTHOR), Schirrmacher-Memmel, Silke11 (AUTHOR), Hellmis, Eva12 (AUTHOR), Fieseler, Claus F.13 (AUTHOR), Doehn, Christian14 (AUTHOR), Ziske, Carsten15 (AUTHOR), Distelrath, Andrea16 (AUTHOR), Marschner, Norbert17 (AUTHOR), Ivanyi, Philipp18 (AUTHOR), Herold, Martin19 (AUTHOR), Loehr, Bianca I.19,20 (AUTHOR) |
| Source: | Cancers. Dec2025, Vol. 17 Issue 24, p3910. 15p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
